Endogenous stem cell stimulation

Endogenous stem cell stimulation is a therapeutic strategy aimed at activating resident stem cells within their native niches to promote tissue repair and regeneration (Nature, 2017). This approach bypasses the logistical and immunological challenges of exogenous cell transplantation by utilizing small molecules, growth factors, or gene therapies to modulate conserved signaling pathways, such as Wnt/beta-catenin, Notch, and Hedgehog, which govern stem cell self-renewal and differentiation (PubMed, 2021). Clinical applications are most established in hematology, where agents like Granulocyte Colony-Stimulating Factor (G-CSF) are used to mobilize hematopoietic stem cells from the bone marrow into the peripheral blood for harvest or recovery (StatPearls, 2023). Beyond hematology, research focuses on stimulating neural stem cells to treat neurodegenerative diseases and mesenchymal stem cells for musculoskeletal repair (Frontiers in Cell and Developmental Biology, 2020). While promising, therapeutic interventions must be finely tuned to avoid significant safety risks, most notably the potential for oncogenic transformation or the exhaustion of the endogenous stem cell pool (Cell Stem Cell, 2019). The efficacy of such treatments is typically monitored using biomarkers like CD34+ cell counts or tissue-specific markers such as LGR5 (UniProt, 2024).

Other names

Endogenous stem cell activationIn situ tissue regenerationEndogenous regenerative medicineResident stem cell mobilization

Activation of quiescent resident stem cells through the pharmacological modulation of signaling pathways (e.g., Wnt, Notch, Sonic Hedgehog) or the mobilization of stem cells from their niches into circulation or damaged tissues to facilitate functional repair (Nature, 2017; PubMed, 2021).